Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
COX7B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
KDM6A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LOC100294033 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
SERINC1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
CUL2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
BCOR - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FAM133DP - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PPP1CB - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PSMD7 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
KRIT1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
FAM49B - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
PCMT1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
LINC00998 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
GEO DataSets Gene Profile neighbors Chromosome neighbors
VTA1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
VPS13A - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
NFE2L2 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
APAF1 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RHEB - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RAB21 - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
RICTOR - Multiple myeloma cell lines with acquired resistance to chemotherapeutic agent carfilzomib
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on